Proportional Hazards Models
"Proportional Hazards Models" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
Descriptor ID |
D016016
|
MeSH Number(s) |
E05.318.740.500.700 E05.318.740.600.700 E05.318.740.750.725 E05.318.740.998.825 E05.599.835.900 N05.715.360.750.530.650 N05.715.360.750.625.650 N05.715.360.750.695.650 N05.715.360.750.795.825 N06.850.520.830.500.700 N06.850.520.830.600.700 N06.850.520.830.750.725
|
Concept/Terms |
Proportional Hazards Models- Proportional Hazards Models
- Proportional Hazard Models
- Hazard Model, Proportional
- Hazard Models, Proportional
- Model, Proportional Hazard
- Models, Proportional Hazard
- Proportional Hazard Model
- Models, Proportional Hazards
- Hazards Model, Proportional
- Hazards Models, Proportional
- Model, Proportional Hazards
- Proportional Hazards Model
Hazards Models- Hazards Models
- Hazards Model
- Model, Hazards
- Models, Hazards
- Hazard Models
- Hazard Model
- Model, Hazard
- Models, Hazard
|
Below are MeSH descriptors whose meaning is more general than "Proportional Hazards Models".
Below are MeSH descriptors whose meaning is more specific than "Proportional Hazards Models".
This graph shows the total number of publications written about "Proportional Hazards Models" by people in this website by year, and whether "Proportional Hazards Models" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 11 | 12 |
1995 | 1 | 11 | 12 |
1996 | 0 | 9 | 9 |
1997 | 0 | 8 | 8 |
1998 | 0 | 22 | 22 |
1999 | 1 | 13 | 14 |
2000 | 0 | 21 | 21 |
2001 | 0 | 24 | 24 |
2002 | 1 | 29 | 30 |
2003 | 0 | 46 | 46 |
2004 | 2 | 57 | 59 |
2005 | 0 | 51 | 51 |
2006 | 1 | 63 | 64 |
2007 | 0 | 75 | 75 |
2008 | 3 | 67 | 70 |
2009 | 2 | 89 | 91 |
2010 | 2 | 97 | 99 |
2011 | 3 | 134 | 137 |
2012 | 3 | 113 | 116 |
2013 | 0 | 149 | 149 |
2014 | 1 | 155 | 156 |
2015 | 0 | 167 | 167 |
2016 | 2 | 157 | 159 |
2017 | 0 | 161 | 161 |
2018 | 0 | 92 | 92 |
2019 | 0 | 92 | 92 |
2020 | 0 | 78 | 78 |
2021 | 1 | 55 | 56 |
2022 | 0 | 23 | 23 |
2023 | 0 | 19 | 19 |
2024 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proportional Hazards Models" by people in Profiles.
-
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator. J Clin Oncol. 2024 Apr 01; 42(10):1169-1180.
-
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2024 Apr; 71(4):e30847.
-
Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era. ESMO Open. 2024 Feb; 9(2):102193.
-
Complete Coronary Revascularization and Outcomes in Patients Who Underwent Coronary Artery Bypass Grafting: Insights from The REGROUP Trial. Am J Cardiol. 2024 Apr 15; 217:127-135.
-
Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2547-2556.
-
Sinonasal NUT carcinoma: A consecutive case series and systematic review. Head Neck. 2024 Jan; 46(1):29-36.
-
Real-World Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma. Clin Genitourin Cancer. 2024 04; 22(2):115-125.e3.
-
Urinary miRNAs Predict Metastasis in Patients With Clinically Localized Clear Cell Renal Cell Carcinoma Treated With Nephrectomy. Clin Genitourin Cancer. 2024 02; 22(1):e156-e162.e4.
-
Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System. Dig Dis Sci. 2023 09; 68(9):3634-3643.
-
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. Neuro Oncol. 2023 Jul 06; 25(7):1310-1320.